AstraZeneca
AZN
#45
Rank
S$378.35 B
Marketcap
S$244.05
Share price
-0.37%
Change (1 day)
19.21%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): S$7.03

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$6.83. In 2024 the company made an earnings per share (EPS) of S$5.79 an increase over its 2023 EPS that were of S$4.90.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$7.0321.43%
2024S$5.7918.23%
2023S$4.9081.13%
2022S$2.70631.03%
2021S$0.37-88.11%
2020S$3.11136.89%
2019S$1.31-39.41%
2018S$2.17-28.27%
2017S$3.02-14.37%
2016S$3.5324.11%
2015S$2.85127.55%
2014S$1.25-51.96%
2013S$2.60-58.95%
2012S$6.34-32.2%
2011S$9.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.21 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.39 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.74-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.78-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.37 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.63-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$14.02 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.32 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.79-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.81-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK